Novel markers for tying-up in horses by proteomics analysis of equine muscle biopsies.

The researchers conducted a study to uncover new biological markers, or biomarkers, for diagnosing a horse condition known as ‘tying-up‘, by analysing proteins in horse muscle biopsies. Their findings indicate a particular form of the muscle protein creatine kinase M chain (CKM) could serve as a potentially useful new biomarker.

Methodology

• The investigators collected muscle biopsies from both healthy horses and those suffering from acute tying-up – a disorder leading to muscle stiffness and pain post-exercise in equines.
• They used techniques called 2D gel electrophoresis and mass spectrometry to identify any proteins that were expressed differently in the ‘tying-up’ samples compared to the healthy ones. This involves separating proteins by size and charge, creating a map of distinct protein ‘spots’ which can be analysed.
• Post-separation, spots indicating a more than two-fold difference in abundance (statistically significant, p<0.05) between sample groups were chosen for further analysis.
• These proteins were then extracted from the gel and subjected to enzymatic digestion, followed by peptide mass fingerprinting to reveal their identity.

Findings

• They found 14 protein spots displayed an expression difference of greater than two-fold. Three proteins – alpha actin, tropomyosin alpha chain, and CKM – were significantly increased in the ‘tying-up’ samples.
• The CKM protein, particularly interesting due to its role in energy production within muscle cells, was represented by multiple spots indicating existence of different forms, or isoforms. One specific isoform of CKM only seemed to be present in the ‘tying-up’ group.

Implications

• This research implies differences in muscle protein expression could underlie the symptoms associated with the ‘tying-up’ condition.
• The finding of a ‘tying-up’ exclusive CKM isoform suggests that changes in energy management within muscle cells are implicated in the condition. This CKM isoform may serve as a new specific biomarker for ‘tying-up’.
• The discovery of such biomarkers not only aids diagnosis but potentially uncovers new avenues for treatment, fostering understanding about the underlying mechanisms that lead to the condition.